CRISPR Therapeutics AG (CRSP)
60.83
+3.76
(+6.58%)
USD |
NASDAQ |
Aug 25, 16:00
60.83
0.00 (0.00%)
After-Hours: 16:06
CRISPR Therapeutics EPS Diluted (Quarterly) : -0.9445 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.9445 |
| March 31, 2026 | -1.280 |
| December 31, 2025 | -1.371 |
| September 30, 2025 | -1.166 |
| June 30, 2025 | -2.395 |
| March 31, 2025 | -1.582 |
| December 31, 2024 | -0.4366 |
| September 30, 2024 | -1.008 |
| June 30, 2024 | -1.488 |
| March 31, 2024 | -1.425 |
| December 31, 2023 | 1.099 |
| September 30, 2023 | -1.412 |
| June 30, 2023 | -0.9829 |
| March 31, 2023 | -0.6745 |
| December 31, 2022 | -1.412 |
| September 30, 2022 | -2.237 |
| June 30, 2022 | -2.397 |
| March 31, 2022 | -2.324 |
| December 31, 2021 | -1.843 |
| September 30, 2021 | -1.667 |
| June 30, 2021 | 9.437 |
| March 31, 2021 | -1.509 |
| Date | Value |
|---|---|
| December 31, 2020 | -1.502 |
| September 30, 2020 | -1.318 |
| June 30, 2020 | -1.297 |
| March 31, 2020 | -1.146 |
| December 31, 2019 | 0.5071 |
| September 30, 2019 | 2.403 |
| June 30, 2019 | -1.010 |
| March 31, 2019 | -0.9293 |
| December 31, 2018 | -0.9207 |
| September 30, 2018 | -1.07 |
| June 30, 2018 | -0.8193 |
| March 31, 2018 | -0.6169 |
| December 31, 2017 | 0.0035 |
| September 30, 2017 | -0.62 |
| June 30, 2017 | -0.56 |
| March 31, 2017 | -0.54 |
| December 31, 2016 | 0.4305 |
| September 30, 2016 | -2.77 |
| June 30, 2016 | -0.4359 |
| March 31, 2016 | -0.2144 |
| June 30, 2015 | -0.0925 |
| March 31, 2015 | -0.0822 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -91.15M |
| Revenue (Quarterly) | 10.18M |
| Total Expenses (Quarterly) | 101.34M |
| Enterprise Value | 3.936B |
| Gross Profit Margin (Quarterly) | -337.8% |
| Profit Margin (Quarterly) | -895.3% |
| Earnings Yield | -7.83% |
| Normalized Earnings Yield | -7.863 |